Literature DB >> 14563101

Anxiety disorders in women.

Teresa A Pigott1.   

Abstract

Women have higher overall prevalence rates for anxiety disorders than men. Women are also much more likely than men to meet lifetime criteria for each of the specific anxiety disorders: generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), social anxiety disorder (SAD), posttraumatic stress disorder (PTSD), simple phobia, panic disorder, and agoraphobia. Considerable evidence suggests that anxiety disorders remain underrecognized and undertreated despite their association with increased morbidity and severe functional impairment. Increasing evidence suggests that the onset, presentation, clinical course, and treatment response of anxiety disorders in women are often distinct from that associated with men. In addition, female reproductive hormone cycle events appear to have a significant influence on anxiety disorder onset, course, and risk of comorbid conditions throughout a woman's life. Further investigations concerning the unique features present in women with anxiety disorders are needed and may represent the best strategy to increase identification and optimize treatment interventions for women afflicted with these long-neglected psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563101     DOI: 10.1016/s0193-953x(03)00040-6

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  42 in total

1.  Overexpression or knockdown of rat tryptophan hyroxylase-2 has opposing effects on anxiety behavior in an estrogen-dependent manner.

Authors:  R Hiroi; R A McDevitt; P A Morcos; M S Clark; J F Neumaier
Journal:  Neuroscience       Date:  2010-12-20       Impact factor: 3.590

2.  Estrogen decreases 5-HT1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: inverse association between gene expression and anxiety behavior in the open field.

Authors:  R Hiroi; J F Neumaier
Journal:  Neuroscience       Date:  2008-11-01       Impact factor: 3.590

3.  Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction.

Authors:  K Lebrón-Milad; A Tsareva; N Ahmed; M R Milad
Journal:  Behav Brain Res       Date:  2013-07-22       Impact factor: 3.332

4.  Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems.

Authors:  M R Arnold; P H Williams; J A McArthur; A R Archuleta; C E O'Neill; J E Hassell; D G Smith; R K Bachtell; C A Lowry
Journal:  Neuropharmacology       Date:  2018-12-20       Impact factor: 5.250

5.  Acute hypernatremia exerts an inhibitory oxytocinergic tone that is associated with anxiolytic mood in male rats.

Authors:  Charles J Frazier; Dipanwita Pati; Helmut Hiller; Dan Nguyen; Lei Wang; Justin A Smith; Kaley MacFadyen; Annette D de Kloet; Eric G Krause
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

6.  Anxiety among informal hospice caregivers: an exploratory study.

Authors:  Karla T Washington; George Demiris; Kenneth C Pike; Robin L Kruse; Debra Parker Oliver
Journal:  Palliat Support Care       Date:  2014-02-13

Review 7.  Stress is a principal factor that promotes tobacco use in females.

Authors:  Oscar V Torres; Laura E O'Dell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-22       Impact factor: 5.067

Review 8.  Sex differences in anxiety and emotional behavior.

Authors:  Nina C Donner; Christopher A Lowry
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

Review 9.  Neuroendocrine pathways underlying risk and resilience to PTSD in women.

Authors:  Meghna Ravi; Jennifer S Stevens; Vasiliki Michopoulos
Journal:  Front Neuroendocrinol       Date:  2019-09-19       Impact factor: 8.606

10.  Inhibition of fear is differentially associated with cycling estrogen levels in women.

Authors:  Ebony M Glover; Kristina B Mercer; Seth D Norrholm; Michael Davis; Erica Duncan; Bekh Bradley; Kerry J Ressler; Tanja Jovanovic
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.